Fleming Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Fleming Pharmaceuticals's estimated annual revenue is currently $9.6M per year.
- Fleming Pharmaceuticals's estimated revenue per employee is $247,385
Employee Data
- Fleming Pharmaceuticals has 39 Employees.
- Fleming Pharmaceuticals grew their employee count by -2% last year.
Fleming Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | Executive Administrative Assistant | Reveal Email/Phone |
Fleming Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2591.1M | 8057 | 7% | N/A | N/A |
#2 | $13.1M | 55 | 2% | N/A | N/A |
#3 | $9.6M | 38 | -5% | N/A | N/A |
#4 | $12.5M | 82 | 61% | N/A | N/A |
#5 | $43.8M | 199 | 11% | N/A | N/A |
#6 | $1.8M | 18 | 64% | N/A | N/A |
#7 | $6.6M | 25 | -7% | N/A | N/A |
#8 | $11.7M | 54 | 13% | N/A | N/A |
#9 | $1104.4M | 3369 | 3% | $97M | N/A |
#10 | $21.3M | 76 | -14% | N/A | N/A |
What Is Fleming Pharmaceuticals?
Specializing in the development and manufacture of innovative prescription and over-the-counter (OTC) therapies, privately held Fleming Pharmaceuticals is the proud maker of MAGONATE®, NEPHROCAPS®, NEPHROCAPS® QT, ThyroShield®, ProBarimin QT® and the OCEAN® Nasal Care line of products. Established in 1960, the company has developed products for a variety of clinical conditions in allergy, pediatrics, nephrology, nutrition, and obstetrics/gynecology. Based in the greater St. Louis area, our fully integrated headquarter facility houses state-of-the-art liquid and solid pharmaceutical manufacturing and packaging, analytical microbiological laboratories, research and development, distribution, marketing, and business administration functions.
keywords:N/AN/A
Total Funding
39
Number of Employees
$9.6M
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8.9M | 39 | 0% | N/A |
#2 | $35M | 39 | 105% | N/A |
#3 | $9.2M | 39 | 18% | N/A |
#4 | $8.2M | 41 | 0% | N/A |
#5 | $4.6M | 41 | 8% | N/A |